Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3085-3091

  Ahmed Bentley, Jasmine ^a,b   Chandran, A Uma ^a,c   Joffe, A Mark ^a,c   French, Desiree ^b   Peirano, Gisele ^d   Pitout, Johann D D ^d,e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DynaLIFE Dx   (Canada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

^d CALGARY LABORATORY SERVICES   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE IMP; BETA LACTAMASE KPC; BETA LACTAMASE NDM; BETA LACTAMASE OXA 48; BETA LACTAMASE VIM; CARBAPENEMASE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CANADA; CLINICAL ARTICLE; EPIDEMIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FALSE POSITIVE RESULT; FEMALE; HOSPITALIZATION; HUMAN; INDIA; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING;

EID: 84879029761     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00297-13     Document Type: Article

References (46)

1. Paterson DL. 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 34:S20-S28, S64-S73.
2. Livermore DM, Woodford N. 2006. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420. (Pubitemid 44233298)
3. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
4. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.
5. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. 2011. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob. Agents Chemother. 55:1274-1278.
6. Castanheira M, Mendes RE, Woosley LN, Jones RN. 2011. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY Antimicrobial Surveillance Programme (2007-09). J. Antimicrob. Chemother. 66:1409-1411.
7. Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, Hoban D, Bonomo RA. 2011. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J. Antimicrob. Chemother. 66:1992-1997.
8. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362.
9. van der Bij AK, Pitout JD. 2012. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J. Antimicrob. Chemother. 67:2090-2100.
10. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
11. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12: 826-836. (Pubitemid 44151282)
12. Durante-Mangoni E, Zarrilli R. 2011. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 6:407-422.
13. Dallo SF, Weitao T. 2010. Insights into acinetobacter war-wound infections, biofilms, and control. Adv. Skin Wound Care 23:169-174.
14. Chandran A, Wolfe AL, Manca S, Ahmed-Bentley J, Pitout JD, Barclay J, Joffe AM. 2012. Investigation of multiple multidrug-resistant Gramnegative bacilli outbreak in a Canadian hospital (or Help!! We have CRE!!), abstr. 1402. ID Week 2012. https://idsa.confex.com/idsa/2012/webprogram/Paper35866.html.
15. Centers for Disease Control and Prevention. 2012. 2012 CRE toolkit-guidance for the control of carbapenem-resistant Enterobacteriaceae (CRE). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hai/organisms/cre/cre-toolkit/.
16. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
17. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, Laupland KB. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286. (Pubitemid 46586806)
19. Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JD. 2011. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn. Microbiol. Infect. Dis. 71:106-109.
20. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. 2012. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J. Clin. Microbiol. 50:3877-3880.
21. Afzal-Shah M, Woodford N, Livermore DM. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588. (Pubitemid 32105297)
22. Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67:1597-1606.
23. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874. (Pubitemid 44198719)
24. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88. (Pubitemid 43050081)
25. Yamane K, Wachino J, Suzuki S, Arakawa Y. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52:1564-1566. (Pubitemid 351522037)
26. Doi Y, Arakawa Y. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45: 88-94. (Pubitemid 46984623)
27. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, Wrigley D, Barrett T, Ribot E. 2005. Establishment of a universal size standard strain for use with the Pulse Net standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 43:1045-1050. (Pubitemid 40364915)
28. Pitout JD, Chow BL, Gregson DB, Laupland KB, Elsayed S, Church DL. 2007. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J. Clin. Microbiol. 45:294-298.
29. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
30. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182. (Pubitemid 41129719)
31. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119-123.
32. Kohlenberg A, Brummer S, Higgins PG, Sohr D, Piening BC, de Grahl C, Halle E, Ruden H, Seifert H. 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J. Med. Microbiol. 58:1499-1507.
33. Hrabak J, Stolbova M, Studentova V, Fridrichova M, Chudackova E, Zemlickova H. 16 February 2012. NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011. Euro Surveill. 17(7):pii=20085. http://www.eurosurveillance.org/ViewArticle.aspx? Articleid=20085.
34. Centers for Disease Control and Prevention. 2012. Carbapenemresistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients-Rhode Island, March 2012. MMWR Morb. Mortal. Wkly. Rep. 61(24):446-448.
35. Lowe CF, Kus JV, Salt N, Callery S, Louie L, Khan MA, Vearncombe M, Simor AE. 2013. Nosocomial transmission of New Delhi metallo-betalactamase-1- producing Klebsiella pneumoniae in Toronto, Canada. Infect. Control Hosp. Epidemiol. 34:49-55.
36. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. 2008. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 116:302-308. (Pubitemid 351499162)
37. Nielsen JB, Skov MN, Jorgensen RL, Heltberg O, Hansen DS, Schonning K. 2011. Identification of CTX-M15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated Rep-PCR typing assay. Eur. J. Clin. Microbiol. Infect. Dis. 30:773-778.
38. Seki LM, Pereira PS, de Souza MDPAH, Conceicao MDS, Marques EA, Porto CO, Colnago EML, Alves CDFM, Gomes D, Assef APDAC, Samuelsen O, Asensi MD. 2011. Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn. Microbiol. Infect. Dis. 70:274-277.
39. Oteo J, Hernandez JM, Espasa M, Fleites A, Saez D, Bautista V, Perez-Vazquez M, Fernandez-Garcia MD, Delgado-Iribarren A, Sanchez-Romero I, Garcia-Picazo L, Miguel MD, Solis S, Aznar E, Trujillo G, Mediavilla C, Fontanals D, Rojo S, Vindel A, Campos J. 2013. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J. Antimicrob. Chemother. 68:317-321.
40. Endimiani A, Hujer KM, Hujer AM, Bertschy I, Rossano A, Koch C, Gerber V, Francey T, Bonomo RA, Perreten V. 2011. Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J. Antimicrob. Chemother. 66:2248-2254.
41. Vrioni G, Daniil I, Voulgari E, Ranellou K, Koumaki V, Ghirardi S, Kimouli M, Zambardi G, Tsakris A. 2012. Comparative evaluation of a prototype chromogenic medium (Chrom ID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs. J. Clin. Microbiol. 50:1841-1846.
42. Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 50:477-479.
43. Bonnin RA, Naas T, Poirel L, Nordmann P. 2012. Phenotypic, biochemical, and molecular techniques for detection of metallo-beta-lactamase NDM in Acinetobacter baumannii. J. Clin. Microbiol. 50:1419-1421.
44. Segal H, Elisha BG. 2005. Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii. J. Antimicrob. Chemother. 56:598. doi:10.1093/jac/dki265. (Pubitemid 41264144)
45. Dortet L, Poirel L, Nordmann P. 2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother. 56:6437-6440.
46. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. 2011. Country-tocountry transfer of patients and the risk of multi-resistant bacterial infection. Clin. Infect. Dis. 53:49-56.